Join to View Full Profile
UTHealth Neurosciences- Texas Medical Center6400 Fannin St. Ste 2800, Dept Of NeurosurgeryHouston, TX 77030
Phone+1 713-486-8000
Fax+1 713-795-8104
Dr. Zhu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Massachusetts General HospitalFellowship, Neuro-Oncology, 2003 - 2005
Tufts Medical CenterResidency, Neurology, 2000 - 2003
Berkshire Medical CenterInternship, Internal Medicine, 1999 - 2000
McGill University Faculty of MedicineClass of 1999
Certifications & Licensure
TX State Medical License 2010 - 2025
MA State Medical License 2005 - 2012
American Board of Psychiatry and Neurology Neurology
United Council for Neurologic SubspecialtiesNeuro-oncology
Clinical Trials
- 131-I-TM-601 Study in Adults With Solid Tumors Start of enrollment: 2006 Aug 01
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Glioblastoma IDH-wild type: imaging independent predictors of gross total resection (GTR) using the VASARI feature set and tumoral volumetric measurements.David Timaran-Montenegro, Luis Nunez, Antonio Dono, Octavio Arevalo, Andres Rodriguez
Acta Radiologica. 2025-03-13 - Targeting tGLI1, a novel mediator of tumor therapeutic resistance, using Ketoconazole sensitizes glioblastoma to CDK4/6 therapy and chemoradiation.Yang Yu, Austin Arrigo, Ankush Chandra, Chuling Zhuang, Mariana K Najjar
Biorxiv. 2025-02-26 - 3 citationsDual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers.Angelina T Regua, Shivani Bindal, Mariana K Najjar, Chuling Zhuang, Munazza Khan
Cancer Letters. 2024-08-10
Press Mentions
Cancer-Killing Virus plus Immunotherapy Boosts Survival in Aggressive Brain CancerMay 19th, 2023- 'He's My Miracle': Houston Man with Brain Tumor Given Two Months to Live, but He's Still Alive Six Years LaterJuly 18th, 2022
Professional Memberships
- Member
- Member
- Society of Neuro-oncologyMember
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
